OCULAR THERAPEUTIX
LIVE

Serial Number

99259760

Owner

OCULAR THERAPEUTIX, INC.

Attorney

Matthew P. Hintz, Esq.

Filing Date

Jun 30, 2025

Add to watchlist:

No watchlists yet
View on USPTO

OCULAR THERAPEUTIX Trademark

Serial Number: 99259760

OCULAR THERAPEUTIX is a trademark filed by OCULAR THERAPEUTIX, INC. on June 30, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

OCULAR THERAPEUTIX, INC.

15 Crosby Drive
Bedford, MA 01730

Entity Type: 03

Trademark Details

Filing Date

June 30, 2025

Registration Date

Not Registered

Published for Opposition

January 20, 2026

Goods & Services

Research and development in the field of pharmaceuticals and biopharmaceuticals; Product development in the field of pharmaceutical and biopharmaceutical preparations, inserts being implantable intravitreal drug delivery devices, implants, and medicines; Development of pharmaceutical preparations and medicines; Product development in the field of pharmaceuticals and biopharmaceuticals

Pharmaceutical preparations for the treatment of ophthalmic diseases and conditions; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of glaucoma, dry eye disease, macular degeneration, and lowering intraocular pressure, namely, ophthalmic pharmaceutical preparations that are delivered using implantable intravitreal drug delivery devices that are filled and sold with ophthalmic pharmaceutical preparations; Pharmaceutical preparations for the treatment of glaucoma, dry eye disease, and macular degeneration; Pharmaceutical preparations for the treatment of lowering intraocular pressure; Pharmaceutical preparations for the treatment of eye diseases and conditions, namely, dexamethasone that is delivered using implantable intravitreal drug delivery devices that are filled and sold with dexamethasone; Pharmaceutical preparations for the treatment of post-op pain and inflammation of the eye, and itching associated with allergic conjunctivitis, namely dexamethasone that is delivered using implantable intravitreal drug delivery devices that are filled and sold with dexamethasone; Ophthalmic preparations

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 3, 2026 EXRA
SOU EXTENSION 1 GRANTED
Jun 2, 2026 EX1G
SOU EXTENSION 1 FILED
Jun 2, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 2, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 17, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 20, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jan 20, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 14, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 18, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 17, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 17, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 17, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 18, 2025 GNRN
NON-FINAL ACTION E-MAILED
Nov 18, 2025 GNRT
NON-FINAL ACTION WRITTEN
Nov 18, 2025 CNRT
ASSIGNED TO EXAMINER
Nov 18, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Nov 7, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 7, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jun 30, 2025 MAFR
NEW APPLICATION ENTERED
Jun 30, 2025 NWAP